InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,216.00
(
-0.09%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.15
(
-0.36%
)
Bitcoin
70,004.19
(
-0.18%
)
Post# of 251889
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: oc631 post# 169195

Saturday, 11/02/2013 3:29:02 PM

Saturday, November 02, 2013 3:29:02 PM

Post# of 251889

Twelve-week (n=24), Sofo/PegRiba SVR rates of 83% puts the option within the same range as 24-weeks of oral.

Even if the oral had been 10% less potent, would you not prefer it?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up